Polysaccharide NAP-3 Synergistically Enhances the Efficiency of Metformin in Type 2 Diabetes via Bile Acid/GLP-1 Axis through Gut Microbiota Remodeling.
多醣體 NAP-3 透過腸道微生物重塑,協同增強 Metformin 在 2 型糖尿病中的療效,作用於膽酸/GLP-1 軸。
J Agric Food Chem 2024-09-12
Anti-diabetic drug use and reduced risk of Parkinson's disease: A community-based cohort study.
抗糖尿病藥物使用與帕金森病風險降低:一項社區基礎的隊列研究。
Parkinsonism Relat Disord 2024-09-11
Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now.
使用四大療法減緩2型糖尿病患者慢性腎病的進展:行動的時刻就是現在。
Drugs 2024-09-11
Swimming training prevents obesity installation and normalizes hypothalamic expressions of GLP1 and leptin receptors in adult offspring born in small litters.
游泳訓練可防止肥胖的形成,並正常化小窩出生的成年後代下丘腦中 GLP1 和 leptin 受體的表達。
Einstein (Sao Paulo) 2024-09-11
Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress.
Daphnetin 調節 GLP-1R 以減輕糖尿病中的認知功能障礙:對炎症和氧化壓力的啟示。
Front Pharmacol 2024-09-11
Anti-Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps.
兒童與青少年肥胖管理中的抗肥胖藥物:近期發展與研究空白。
Clin Endocrinol (Oxf) 2024-09-11
The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis.
semaglutide 在卵巢切除大鼠骨質疏鬆模型中對骨保護作用的關鍵角色:β-catenin 的作用。
Naunyn Schmiedebergs Arch Pharmacol 2024-09-10